Compliance Management White Papers & Case Studies
-
Serialization And The Drug Quality & Security Act: A Top-Down Synergistic Approach
By Mike Salinas, M&W Group, and David DeJean, Systech International
Hang around pharmaceutical drug manufacturers long enough and the conversation will undoubtedly turn to the global dilemma of safeguarding the public from the proliferation of counterfeit drugs, and the Drug Quality and Security Act (DQSA).
This website uses cookies to ensure you get the best experience on our website. Learn more